Home
ARDX
ARDX News

Latest Ardelyx Inc. (ARDX) News on October 18, 2024

Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024

GlobeNewswire

14 hours ago

Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week

GlobeNewswire

3 days ago

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week

Ardelyx Inc (ARDX) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Challenges

GuruFocus.com

8 days ago

Ardelyx Inc (ARDX) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Challenges

Even though Ardelyx (NASDAQ:ARDX) has lost US$210m market cap in last 7 days, shareholders are still up 352% over 3 years

Simply Wall St.

8 days ago

Even though Ardelyx (NASDAQ:ARDX) has lost US$210m market cap in last 7 days, shareholders are still up 352% over 3 years

Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology

GlobeNewswire

9 days ago

Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology

Wall Street Analysts Think Ardelyx (ARDX) Could Surge 65.4%: Read This Before Placing a Bet

Zacks

10 days ago

Wall Street Analysts Think Ardelyx (ARDX) Could Surge 65.4%: Read This Before Placing a Bet

MT Newswires

16 days ago

Ardelyx Insider Sold Shares Worth $342,983, According to a Recent SEC Filing

Top High Growth Tech Stocks to Watch in September 2024

Simply Wall St.

a month ago

Top High Growth Tech Stocks to Watch in September 2024

Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference

GlobeNewswire

a month ago

Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference

With 62% ownership, Ardelyx, Inc. (NASDAQ:ARDX) boasts of strong institutional backing

Simply Wall St.

2 months ago

With 62% ownership, Ardelyx, Inc. (NASDAQ:ARDX) boasts of strong institutional backing

Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer

GlobeNewswire

2 months ago

Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer

Here's What Key Metrics Tell Us About Ardelyx (ARDX) Q2 Earnings

Zacks

3 months ago

Here's What Key Metrics Tell Us About Ardelyx (ARDX) Q2 Earnings

Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates

Zacks

3 months ago

Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates

Associated Press Finance

3 months ago

Ardelyx: Q2 Earnings Snapshot

Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

3 months ago

Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update

Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion

GlobeNewswire

3 months ago

Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion

Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know

Zacks

3 months ago

Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know

Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

3 months ago

Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?

Ardelyx sues CMS over revamped kidney disease drug payment bundle

Pharmaceutical Technology

3 months ago

Ardelyx sues CMS over revamped kidney disease drug payment bundle

MT Newswires

3 months ago

Ardelyx, Groups File Lawsuit Over Dialysis Payment System Coverage

Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024

GlobeNewswire

3 months ago

Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024

Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines

GlobeNewswire

3 months ago

Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines

Enanta Pharmaceuticals (ENTA) Soars 6.7%: Is Further Upside Left in the Stock?

Zacks

3 months ago

Enanta Pharmaceuticals (ENTA) Soars 6.7%: Is Further Upside Left in the Stock?

MT Newswires

3 months ago

HC Wainwright Adjusts Ardelyx's Price Target to $10 From $13, Keeps Buy Rating

MT Newswires

4 months ago

Wedbush Adjusts Ardelyx's Price Target to $11 From $15, Keeps Outperform Rating

MT Newswires

4 months ago

Sector Update: Health Care Stocks Lean Lower Premarket Tuesday

MT Newswires

4 months ago

Sector Update: Health Care

MT Newswires

4 months ago

Update: Ardelyx Opts Out of CMS Payment Adjustment for Xphozah; Shares Plunge Pre-Bell

MT Newswires

4 months ago

Ardelyx Opts Out of CMS Payment Adjustment for Xphozah

To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA

GlobeNewswire

4 months ago

To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA

Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines

GlobeNewswire

4 months ago

Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines

When Will Ardelyx, Inc. (NASDAQ:ARDX) Become Profitable?

Simply Wall St.

4 months ago

When Will Ardelyx, Inc. (NASDAQ:ARDX) Become Profitable?

Ardelyx, Inc. Reports Employment Inducement Grants

GlobeNewswire

5 months ago

Ardelyx, Inc. Reports Employment Inducement Grants

MT Newswires

5 months ago

Ardelyx Shares Fall; Chief Commercial Officer Resigns

Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference

GlobeNewswire

5 months ago

Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference

Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

GlobeNewswire

5 months ago

Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)

GlobeNewswire

5 months ago

Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)

Ardelyx, Inc. Reports Employment Inducement Grants

GlobeNewswire

5 months ago

Ardelyx, Inc. Reports Employment Inducement Grants

MT Newswires

5 months ago

Ardelyx Insider Sold Shares Worth $2,522,217, According to a Recent SEC Filing

MT Newswires

5 months ago

Ardelyx Insider Sold Shares Worth $1,831,503, According to a Recent SEC Filing

MT Newswires

5 months ago

Ardelyx Insider Sold Shares Worth $333,574, According to a Recent SEC Filing

Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference

GlobeNewswire

5 months ago

Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference

Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 Earnings Call Transcript

Insider Monkey

5 months ago

Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 Earnings Call Transcript

Ardelyx First Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

5 months ago

Ardelyx First Quarter 2024 Earnings: Beats Expectations

MT Newswires

5 months ago

Ardelyx Shares Rise After Q1 Beat

MT Newswires

5 months ago

Wedbush Adjusts Ardelyx's Price Target to $15 From $14, Keeps Outperform Rating

Thomson Reuters StreetEvents

5 months ago

Q1 2024 Ardelyx Inc Earnings Call

Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates

Zacks

6 months ago

Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates

Associated Press Finance

6 months ago

Ardelyx: Q1 Earnings Snapshot

Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

6 months ago

Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings

GlobeNewswire

6 months ago

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings

Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks

6 months ago

Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks

6 months ago

Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Ardelyx's (NASDAQ:ARDX) investors will be pleased with their favorable 91% return over the last five years

Simply Wall St.

6 months ago

Ardelyx's (NASDAQ:ARDX) investors will be pleased with their favorable 91% return over the last five years

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024

GlobeNewswire

6 months ago

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024

Ardelyx, Inc. Reports Employment Inducement Grants

GlobeNewswire

7 months ago

Ardelyx, Inc. Reports Employment Inducement Grants

Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy

GlobeNewswire

7 months ago

Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy

Institutional investors may overlook Ardelyx, Inc.'s (NASDAQ:ARDX) recent US$195m market cap drop as long-term gains remain positive

Simply Wall St.

7 months ago

Institutional investors may overlook Ardelyx, Inc.'s (NASDAQ:ARDX) recent US$195m market cap drop as long-term gains remain positive

Ardelyx, Inc. Reports Employment Inducement Grants

GlobeNewswire

7 months ago

Ardelyx, Inc. Reports Employment Inducement Grants

The Millionaire’s Watchlist: 3 Stocks Set for a Meteoric Rise

InvestorPlace

8 months ago

The Millionaire’s Watchlist: 3 Stocks Set for a Meteoric Rise

Ardelyx to Participate at the Cowen 44th Annual Health Care Conference

GlobeNewswire

8 months ago

Ardelyx to Participate at the Cowen 44th Annual Health Care Conference

Stocks on the Launchpad: The Next 3 Market Sensations

InvestorPlace

8 months ago

Stocks on the Launchpad: The Next 3 Market Sensations

Ardelyx, Inc. (NASDAQ:ARDX) Q4 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Ardelyx, Inc. (NASDAQ:ARDX) Q4 2023 Earnings Call Transcript

Ardelyx (ARDX) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks

8 months ago

Ardelyx (ARDX) Reports Q4 Earnings: What Key Metrics Have to Say

Ardelyx (ARDX) Reports Q4 Loss, Lags Revenue Estimates

Zacks

8 months ago

Ardelyx (ARDX) Reports Q4 Loss, Lags Revenue Estimates

Ardelyx Inc (ARDX) Reports Robust Revenue Growth and Strategic Advances in 2023

GuruFocus.com

8 months ago

Ardelyx Inc (ARDX) Reports Robust Revenue Growth and Strategic Advances in 2023

Associated Press Finance

8 months ago

Ardelyx: Q4 Earnings Snapshot

Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire

8 months ago

Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know

Zacks

8 months ago

Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know

Ardelyx (ARDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks

8 months ago

Ardelyx (ARDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Wall Street Analysts Believe Ardelyx (ARDX) Could Rally 34.84%: Here's is How to Trade

Zacks

8 months ago

Wall Street Analysts Believe Ardelyx (ARDX) Could Rally 34.84%: Here's is How to Trade

Ardelyx (ARDX) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

8 months ago

Ardelyx (ARDX) Is a Great Choice for 'Trend' Investors, Here's Why

3 Unstoppable Russell 2000 to Buy in February

InvestorPlace

8 months ago

3 Unstoppable Russell 2000 to Buy in February

Ardelyx (ARDX) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

8 months ago

Ardelyx (ARDX) Upgraded to Buy: What Does It Mean for the Stock?

Is Ardelyx (ARDX) Stock Outpacing Its Medical Peers This Year?

Zacks

8 months ago

Is Ardelyx (ARDX) Stock Outpacing Its Medical Peers This Year?

3 Sleeper Stocks Under $15 Ready to Explode by 2029

InvestorPlace

8 months ago

3 Sleeper Stocks Under $15 Ready to Explode by 2029

3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List

InvestorPlace

8 months ago

3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List

The 3 Best Biotech Stocks to Invest in for Big Gains in 2024

InvestorPlace

9 months ago

The 3 Best Biotech Stocks to Invest in for Big Gains in 2024

Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

GlobeNewswire

9 months ago

Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

TELUS International and Morpheus Data Announce Partnership to Deliver Simplified and Agile Hybrid Cloud Platform Operations

Business Wire

9 months ago

TELUS International and Morpheus Data Announce Partnership to Deliver Simplified and Agile Hybrid Cloud Platform Operations

Viasat Sets February 6, 2024 for Third Quarter Fiscal Year 2024 Financial Results Conference Call and Webcast

PR Newswire

9 months ago

Viasat Sets February 6, 2024 for Third Quarter Fiscal Year 2024 Financial Results Conference Call and Webcast

Axos Financial, Inc. Reports Record Second Quarter Fiscal 2024 Results

Business Wire

9 months ago

Axos Financial, Inc. Reports Record Second Quarter Fiscal 2024 Results

Is OSI (OSIS) a Solid Growth Stock? 3 Reasons to Think "Yes"

Zacks

9 months ago

Is OSI (OSIS) a Solid Growth Stock? 3 Reasons to Think "Yes"

3 Groundbreaking Biotech Stocks to Invest in Now

InvestorPlace

9 months ago

3 Groundbreaking Biotech Stocks to Invest in Now

GlobeNewswire

9 months ago

Simplicity Group Unveils WeDYOR: Transforming Due Diligence for Crypto Investments

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

GlobeNewswire

9 months ago

Global Disposable Gloves Market Size is Estimated to Reach USD 20.1 billion by 2031, Growing at a CAGR of 8.21%: Straits Research

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

GlobeNewswire

9 months ago

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Barrons.com

9 months ago

SoFi Stock Soars After Company Posts First-Ever Quarterly Profit

Is Archrock (AROC) Stock Outpacing Its Oils-Energy Peers This Year?

Zacks

9 months ago

Is Archrock (AROC) Stock Outpacing Its Oils-Energy Peers This Year?

Innovative Industrial Properties Announces Tax Treatment of 2023 Distributions

Business Wire

9 months ago

Innovative Industrial Properties Announces Tax Treatment of 2023 Distributions

LyondellBasell's (LYB) Petrothene T3XL7420 to Optimize Production

Zacks

9 months ago

LyondellBasell's (LYB) Petrothene T3XL7420 to Optimize Production

5 Top Growth Stocks to Buy as Recession Fears Subside

Zacks

9 months ago

5 Top Growth Stocks to Buy as Recession Fears Subside

Decoding Logitech International SA (XSWX:LOGN): A Strategic SWOT Insight

GuruFocus.com

9 months ago

Decoding Logitech International SA (XSWX:LOGN): A Strategic SWOT Insight

United Community Banks, Inc. (NASDAQ:UCBI) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

United Community Banks, Inc. (NASDAQ:UCBI) Q4 2023 Earnings Call Transcript

Bank of Hawaii Corporation (NYSE:BOH) Q4 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Bank of Hawaii Corporation (NYSE:BOH) Q4 2023 Earnings Call Transcript

United Community Banks Inc (UCBI) Reports Decline in Q4 Earnings Amid Economic Uncertainty

GuruFocus.com

9 months ago

United Community Banks Inc (UCBI) Reports Decline in Q4 Earnings Amid Economic Uncertainty

Should We Be Delighted With Armstrong World Industries, Inc.'s (NYSE:AWI) ROE Of 39%?

Simply Wall St.

9 months ago

Should We Be Delighted With Armstrong World Industries, Inc.'s (NYSE:AWI) ROE Of 39%?

New Strong Sell Stocks for January 24th

Zacks

9 months ago

New Strong Sell Stocks for January 24th

Triple Flag Announces Time Change of Q4 2023 Results Call

Business Wire

9 months ago

Triple Flag Announces Time Change of Q4 2023 Results Call

Here's Why You Should Hold Onto Huntsman (HUN) Stock For Now

Zacks

9 months ago

Here's Why You Should Hold Onto Huntsman (HUN) Stock For Now

Share on Social Networks: